Breast cancer Flashcards

(40 cards)

1
Q

Who is the breast 2ww service for

A

All patients with a lump/discrete thickening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is involved in the breast triple assessment

A

History and examination

Imaging (mammography, ultrasound)

Biopsy (wide bore needle, fine needle aspiration)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Roughly what percentage of breast cancer patients are male

A

1 %

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the breast screening programme

A

Mammograms every 3 years

For women between 50 and 70

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the clinical categories based on the clinical examination section of a breast triple assessment

A

P1 - normal (no changes, symmetrical changes)

P2 - benign (well-defined mass, benign thickening)

P3 - uncertain (mass, thickening not clearly benign)

P4 - suspicious (ill defined mass with skin thickening/pectoral fixation, retracted nipple)

P5 - malignant (cancer certain)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

When are mammograms used in the triple assessment

A

For people > 35 (breasts not as dense)

Do not detect all cancers (lobular cancers missed)

Not ideal if using HRT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the clinical categories based on mammograms used as part of the breast triple assessment

A

M1 - normal

M2 - benign

M3 - intermediate

M4 - suspicious

M5 - malignant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

When is ultrasound used in the breast triple assessment

A

Not used for screening

Good for lumps and focal lesions

Differentiation between cyst and solid lesion

Differentiation between benign and malignant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the clinical categories based on ultrasound scans used as part of the breast triple assessment

A

U1 - normal

U2 - benign

U3 - uncertain

U4 - suspicious

U5 - malignant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

When is MRI used in breast triple assessment

A

Family history

Dense breasts

Young patients

Lobular cancers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the types of biopsy that can be taken in breast triple assessment

A

Fine needle aspiration

Core biopsy

Punch biopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How is the primary lesion assessed in pre-op staging for breast cancer

A

MRI breast

Biopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How is the axilla assessed in pre-op staging for breast cancer

A

Ultrasound

Biopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How are distant metastases screened for in the pre-op staging of breast cancer

A

Routine bloods

Calcium

Tumour markers (CA 15-3)

CT CAP

Bone scan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

When is surgery used in breast cancer treatment

A

Primary form of therapy in most cases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Explain chemotherapy as a form of adjuvant therapy for breast cancer

A

Aims to reduce annual risk of relapse

All patients < 70 considered

Particularly useful in: young, lymph node positive, high grade, advanced disease

Common drugs: anthracycline, 5-FU, cyclophosphamide

Usually 4-6 cycles, every 3 weeks

Side effects: nausea, vomiting, alopecia, neutropenia

Usually starts 4-6 weeks after surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Explain immunotherapy as a form of adjuvant therapy for breast cancer

A

20-25% overexpress HER-2 receptors

Use herceptin (monoclonal antibody, can cause heart failure)

18
Q

Explain radiotherapy as a form of adjuvant therapy for breast cancer

A

Target lump

Target chest wall (high risk of recurrence)

Target supra-clavicular area (if >3 nodes positive)

19
Q

Explain the follow up involves after breast cancer treatment

A

Clinic follow up for 3 years (5 years if high risk of recurrence)

Annual mammograms for 5 years

Open access to breast clinic and breast care nurses

20
Q

What is the prognostic tool used for breast cancer, what does it involve

A

Nottingham prognostic index

Based on: tumour size, grade, lymph node status

21
Q

Explain normal breast development

A

Female breasts develop under influence of oestrogen and progesterone

Asymmetry is common

Regress after menopause

Between 2nd and 6th rib

Have 15-20 lobes

Supported by Cooper’s suspensory ligament

22
Q

Name the arteries that supply the breast

A

External mammary artery

Internal mammary artery

Intercostal artery

23
Q

What are the types of breast lumps by age of presentation

A

Cancer (risk increases with age)

Fibroadenoma (risk decreases with age, highest risk before 20)

Fibrocystic and cystic changes (peak around age 50)

24
Q

What are the signs and symptoms of breast cancer

A

Lump or thickening in breast (hard, irregular, fixed)

Usually painless

Nipple discharge/bleeding

Change in size or shape of breast

Change in size or colour of areola

Pitting of skin over breast

25
What are fibrocystic breast changes
Non-cancerous Very common in pre-menopausal women Cause discomfort Treatment rarely needed
26
What are fibroadenomas
Most common benign breast tumour In young women Can have multiple lumps If growing, excise
27
What are breast cysts
Benign growths If very large, aspirate Usually multiple cysts Commonly recur
28
What are invasive carcinomas
Invasive ductal carcinoma (80%) Invasive lobular carcinoma (10%) Tubular Papillary Medullary Mucinous
29
What are in situ carcinomas
Ductal carcinoma in situ (DCIS) Lobular carcinoma in situ (LCIS)
30
How does breast cancer normally spread
Lymphatics Vascular extension Direct extension
31
What are the common sites of metastases in breast cancer
Lung Liver Bone Brain Adrenals Ovaries
32
What are the hormonal treatments available for breast cancers
Oestrogen antagonists (tamoxifen) Aromatase inhibitors (arimidex, letrozole, examestane)
33
Explain oestrogen antagonists as a treatment for breast cancer
E.g. Tamoxifen Block oestrogen receptors Suitable for pre- and post-menopausal women Increased risk of DVT Increased risk of endometrial cancer Bone protection
34
Explain aromatase inhibitors as a treatment for breast cancer
E.g. arimidex, letrozole, examestane Prevents oestrogen production in post-menopausal women Low risk of DVT Increased risk of osteoporosis
35
What are the risk factors for the development of breast cancer
Female Increased oestrogen exposure (early menarche, late menopause) More dense breast tissue Obesity Smoking Family history (1st degree relative) COCP (very small increase in risk) HRT (especially combined)
36
What are the specific genes that can increase the risk of breast cancer
BRCA1, BRCA2 TP52 PTEN
37
Which patients are classed as being at high risk of developing breast cancer
1st degree relative with breast cancer under age 40 1st degree male relative with breast cancer 1st degree relative with bilateral breast cancer under age 50 2 1st degree relatives with breast cancer
38
What is involved in risk-management for patients at high risk of developing breast cancer
Genetic counselling Annual mammograms Chemoprevention (tamoxifen if pre-menopausal, anastrazole if post-menopausal) Bilateral mastectomy
39
What is the referral criteria for breast 2ww
Unexplained breast lump in over 30s Unilateral nipple changes in over 50s Unexplained axillary lump in over 30s Skin changes suggestive of cancer
40
Which receptors can be targeted in the treatment of breast cancer
Oestrogen receptor (ER) Progesterone receptor (PR) Human epidermal growth factor (HER2) (Triple negative breast cancer has a poor prognosis)